WHO reportWHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015☆
Keywords
Cited by (0)
- ☆
This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
- 1
WHO RSV Vaccine Consultation Expert Group: Narendra Kumar Arora (The INCLEN Trust International, New Delhi, India). Louis Bont (University Medical Center, Utrecht, The Netherlands). Harry Campbell (Centre for Global Health Research, Edinburgh, UK). Peter Collins (National Institutes of Health, Bethesda, MD, USA). Janet Englund (University of Washington, Seattle, WA, USA). Barney S. Graham (National Institutes of Health, Bethesda, MD, USA). Deborah Higgins (PATH Seattle, WA, USA). Ruth Karron (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA). Keith Klugman (The Bill & Melinda Gates Foundation, Seattle, WA, USA). Ivana Knezevic (World Health Organization, CH-1211 Geneva 27, Switzerland). Shabir A. Madhi (National Institute for Communicable Diseases, Johannesburg, South Africa). Harish Nair (Centre for Global Health Research, Edinburgh, UK). Patricia Njuguna (KEMRI Wellcome Trust, Kilifi, Kenya). James Nokes (KEMRI Wellcome Trust, Kilifi, Kenya; Warwick University, Coventry, UK). Fernando Polack (Fundación INFANT, Buenos Aires, Argentina). Eric A.F. Simoes (University of Colorado Health Sciences Center, Denver, CO, USA). Niteen Wairagkar (The Bill & Melinda Gates Foundation, Seattle, WA, USA). Tiequn Zhou (World Health Organization, CH-1211 Geneva 27, Switzerland).